NeuroSense Cash Flow Coverage Ratios from 2010 to 2024

NRSNW Stock  USD 0.25  0.13  34.21%   
NeuroSense Therapeutics Cash Flow Coverage Ratios yearly trend continues to be fairly stable with very little volatility. Cash Flow Coverage Ratios will likely drop to -48.77 in 2024. During the period from 2010 to 2024, NeuroSense Therapeutics Cash Flow Coverage Ratios regression line of quarterly data had r-squared of  0.30 and coefficient of variation of (2.89). View All Fundamentals
 
Cash Flow Coverage Ratios  
First Reported
2010-12-31
Previous Quarter
(46.44)
Current Value
(48.77)
Quarterly Volatility
1.47488293
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NeuroSense Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeuroSense Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 186.9 K, Depreciation And Amortization of 101.8 K or Interest Expense of 379.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NeuroSense financial statements analysis is a perfect complement when working with NeuroSense Therapeutics Valuation or Volatility modules.
  
Check out the analysis of NeuroSense Therapeutics Correlation against competitors.
For more information on how to buy NeuroSense Stock please use our How to Invest in NeuroSense Therapeutics guide.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NeuroSense Stock Analysis

When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.